Search

Search Constraints

You searched for: Author/Creator Smith, Christopher M

Search Results

8. Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma. Issue 6 (11th June 2021)